Search research articles
Contact Us
Filters
Showing results (201-210 of 258) with videos related to
Page
of 26
Sort By:
Breast Cancer Research and Treatment
|
December 2, 2021
Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing
Phuong Dinh, J Dinny Graham, Elisabeth N Elder, et al.
Nature Cancer
|
August 25, 2022
Checkpoint inhibitor immunotherapy diminishes oocyte number and quality in mice
Amy L Winship, Lauren R Alesi, Sneha Sant, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 16, 2010
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
Sunil Badve, David J Dabbs, Stuart J Schnitt, et al.
JCO Precision Oncology
|
August 29, 2024
Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for Delivery
Kortnye Smith, Sophie O'Haire, Benjamin Markman, et al.
The Journal of Clinical Investigation
|
March 6, 2019
Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion
Christopher R McEvoy, Huiling Xu, Kortnye Smith, et al.
NPJ Digital Medicine
|
September 29, 2024
Blending space and time to talk about cancer in extended reality
Tamsin J Robb, Yinan Liu, Braden Woodhouse, et al.
Genome Medicine
|
October 7, 2025
Pathologist-initiated whole genome and transcriptome sequencing demonstrates diagnostic utility in resolving difficult-to-diagnose tumors
Joseph H A Vissers, Catherine Mitchell, Owen W J Prall, et al.
Nature Medicine
|
August 4, 2009
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
Elgene Lim, François Vaillant, Di Wu, et al.
The American Journal of Surgical Pathology
|
July 7, 2021
SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3
Jia-Min B Pang, Belinda Castles, David J Byrne, et al.
International Journal of Cancer
|
August 14, 2009
Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status
Niamh C Murphy, Andrew V Biankin, Ewan K A Millar, et al.
Page
of 26
Search research articles
Search
Showing results (201-210 of 258) with videos related to
Sort By:
Page
of 26
Breast Cancer Research and Treatment
|
December 2, 2021
Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing
Phuong Dinh, J Dinny Graham, Elisabeth N Elder, et al.
Nature Cancer
|
August 25, 2022
Checkpoint inhibitor immunotherapy diminishes oocyte number and quality in mice
Amy L Winship, Lauren R Alesi, Sneha Sant, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 16, 2010
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
Sunil Badve, David J Dabbs, Stuart J Schnitt, et al.
JCO Precision Oncology
|
August 29, 2024
Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for Delivery
Kortnye Smith, Sophie O'Haire, Benjamin Markman, et al.
The Journal of Clinical Investigation
|
March 6, 2019
Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion
Christopher R McEvoy, Huiling Xu, Kortnye Smith, et al.
NPJ Digital Medicine
|
September 29, 2024
Blending space and time to talk about cancer in extended reality
Tamsin J Robb, Yinan Liu, Braden Woodhouse, et al.
Genome Medicine
|
October 7, 2025
Pathologist-initiated whole genome and transcriptome sequencing demonstrates diagnostic utility in resolving difficult-to-diagnose tumors
Joseph H A Vissers, Catherine Mitchell, Owen W J Prall, et al.
Nature Medicine
|
August 4, 2009
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
Elgene Lim, François Vaillant, Di Wu, et al.
The American Journal of Surgical Pathology
|
July 7, 2021
SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3
Jia-Min B Pang, Belinda Castles, David J Byrne, et al.
International Journal of Cancer
|
August 14, 2009
Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status
Niamh C Murphy, Andrew V Biankin, Ewan K A Millar, et al.
Page
of 26